REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medsyn Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Medsyn Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Medsyn Sdn. Bhd. is a company in Malaysia, with a head office in Petaling Jaya. It operates in the Pharmacies and Drug Stores industry. It was first established on December 21, 2012. The latest financial highlights indicate a net sales revenue increase of 62.8% in 2024. Over the same period, its total assets grew by 15.61%. In 2024, Medsyn Sdn. Bhd.’s net profit margin decreased by 1.23%.

Headquarters
E-1-2, Parklane Commercial Hub, Jalan Ss 7/26, Kelana Jaya
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Medsyn Sdn. Bhd. report to view the information.

Website: http://www.medsyn.com.my

Basic Information
Financial Auditors:
Purchase the Medsyn Sdn. Bhd. report to view the information.
Incorporation Date:
December 21, 2012
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
28.3%
Purchase this report to view the information.
11.7%
Company Performance
Financial values in the chart are available after Medsyn Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
62.8%▲
Total operating revenue
62.8%▲
Operating profit (EBIT)
25.73%▲
EBITDA
25.73%▲
Net Profit (Loss) for the Period
22.04%▲
Total assets
15.61%▲
Total equity
20.16%▲
Operating Profit Margin (ROS)
-1.45%▼
Net Profit Margin
-1.23%▼
Return on Equity (ROE)
0.41%▲
Quick Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo